KI-CDK9d-32
KI-CDK9d-32 is a CDK9 PROTAC degrader (DC50: 0.89 nM). KI-CDK9d-32 promotes the ubiquitination and degradation of CDK9. KI-CDK9d-32 inhibits the MYC pathway and disrupts nucleolar homeostasis. KI-CDK9d-32 has anticancer activity. (Pink: CDK9 ligand ; Blue: E3 ligase CRBN ligand (HY-163233) ; Black: Linker (HY-W011657) ; E3 ligase CRBN ligand-linker conjugate (HY-173525) ).
Product Specifications
CAS Number
3054009-82-1
UNSPSC
12352005
Target
CDK; c-Myc; PROTACs
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; PROTAC
Field of Research
Cancer
Purity
99.0300
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@H]1C[C@H](NC2=CC(CCC)=NC3=CC=NN23)CC1)C4=CC=C(CN5CCN(C6=CC7=C(C(N(C(CC8)C(NC8=O)=O)C7)=O)C=C6)CC5)C=C4
Molecular Formula
C39H45N9O4
Molecular Weight
703.83
References & Citations
[1]Toure MA, et al. Targeted degradation of CDK9 potently disrupts the MYC-regulated network. Cell Chem Biol. 2025 Apr 17;32 (4) :542-555.e10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Gnb3 sgRNA CRISPR Lentivector (Mouse) (Target 1)
